Overview
- 5 public-safe observations are available for this inspection.
- 5 structured CFR citations are represented.
- 2 investigators are tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
15 May 2026
21 CFR 114.100(c)
Process deviations- identification and records
Cited by Sierra M Shockley, Sandra R Saunders
15 May 2026
21 CFR 129.35(a)(4)(iv)
Quality standards - compliance
Cited by Sierra M Shockley, Sandra R Saunders
Inspected site
MBMatrix Bottling Group, LLCMorganton, United States
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 114.100(c) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 114.80(a)(1) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 114.80(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 114.89 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 129.35(a)(4)(iv) | Cited across public-safe Form 483 observations | 1x |
Full 483 report
Get the verbatim text of all 5 observations
The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere